comparemela.com

Latest Breaking News On - St marianna university school of medicine - Page 1 : comparemela.com

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t

Eteläuomen läiSaudi arabiaSri lankaUniversity of minnesotaUnited statesSan franciscoNew south walesCity ofUnited kingdomKrung thep mahanakhonBritish columbiaFrance generalNew zealandWestern australiaNorthern irelandSouth australia

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

United kingdomSouth australiaFrance generalCity ofBritish columbiaUnited statesWestern australiaSan franciscoNew zealand generalNew zealandEstado de pernambucoNational universityEteläuomen läiSao pauloSri lankaAr riya

Cancer patients give birth using frozen ovaries in Japan s first

Three cancer patients in their 30s and 40s have successfully given birth using their ovaries kept frozen while they underwent cancer therapies, according to a Japanese medical school, providing hope to female pediatric cancer patients who have yet to have their periods.

Shizuka ochiMarianna university school of medicineMarianna university school of medicine kyodoMarianna university schoolNao suzukiHyogo prefectureCancer patientsRozen ovariesAncer patients given birthCancer therapiesSt marianna university school of medicine

Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC

Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.

New yorkUnited statesNasserk altorkiHisashi sajiAstellas pharmaMerck sharpe dohmeBristol myers squibbChugai pharmaYork genome centerBoehringer ingelheimTakeda pharmaceutical companyJapan blood products organizationLung cancer study groupJanssen pharmaceuticalsSt marianna university school of medicineWeill cornell medicine

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care u

Nordrhein westfalenCity ofUnited kingdomFrance generalBritish columbiaUnited statesBedford parkSouth australiaFlinders universityWestern australiaSan franciscoNew zealand generalNew zealandEstado de pernambucoNational university of singaporeSingapore general

vimarsana © 2020. All Rights Reserved.